BPL-002 series (Redx Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBPL-002 series (Redx Pharma)
Drug Alias NameBPL-002 series (Bradford Pharma)BPL-002
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCommunicable DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBradford Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBradford PharmaRedx Pharma Plc
Active IndicationsN/A
Inactive IndicationsCommunicable DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A